Author:
Kenney-Jung Daniel,Korlimarla Aditi,Spiridigliozzi Gail A.,Wiggins Walter,Malinzak Michael,Nichting Gretchen,Jung Seung-Hye,Sun Angela,Wang Raymond Y.,Al Shamsi Aisha,Phornphutkul Chanika,Owens James,Provenzale James M.,Kishnani Priya S.
Subject
Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. Postmortem findings and clinical correlates in individuals with infantile-onset Pompe disease;Pena;JIMD Rep.,2015
2. Pompe disease diagnosis and management guideline;Kishnani;Genet. Med.,2006
3. Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy;Desai;Mol. Genet. Metab. Rep.,2019
4. Benefits of prophylactic short-course immune tolerance induction in patients with infantile Pompe disease: demonstration of long-term safety and efficacy in an expanded cohort;Desai;Front. Immunol.,2020
5. Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction;Li;Genet. Med.,2021